ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Confluent Medical Technologies Announces Ultra Polyimide

SCOTTSDALE, Ariz., April 07, 2025 (GLOBE NEWSWIRE) -- Confluent Medical Technologies (Confluent), a leading medical device and materials science contract manufacturer specializing in polymer and metal components, has announced the launch of Ultra Polyimide, the strongest polyimide tubing in the industry. This breakthrough material delivers nearly twice the strength of traditional polyimide, providing unmatched performance and design flexibility for medical device manufacturers.

Traditional polyimide is valued for its high strength and durability, but as medical devices continue to evolve, engineers require thinner walls without sacrificing strength. Ultra Polyimide addresses this challenge by delivering approximately 2x the strength of standard polyimide while preserving critical inner lumen space.

“This advancement enables device designers to reduce material usage while maintaining essential column and tensile strength,” stated Jill Ellison, VP of Operations for Confluent’s High Precision Polymer Tubing Center of Excellence. “This frees up valuable cross-sectional area for additional design elements for the continued advancement in delivery device technology.”

Ultra Polyimide is manufactured without the use of REACH- or EU MDR-restricted solvents, including NMP (n-Methyl-2-pyrrolidone)—a chemical recently flagged by the EPA as posing an unreasonable risk to human health in various industrial applications. By eliminating NMP from its manufacturing process, Confluent ensures regulatory compliance, enhances workplace and patient safety, and protects the long-term stability of the medical device supply chain. Ultra Polyimide is now available with lead times of 3-4 weeks.

About Confluent:

Confluent Applies Materials Science to MedTech Innovation. Confluent specializes in the expert design, development, and large-scale manufacturing of interventional catheter-based devices and implants. Customers rely on Confluent’s expertise in Nitinol material and components, balloon and complex catheters, high-precision polymer tubing, and implantable textiles. With facilities in Fremont and Orange County, California; Warwick, Rhode Island; Windham, Maine; Austin, Texas; Chattanooga, Tennessee; San Jose, Costa Rica; and Hyderabad, India, Confluent has earned the confidence of the leaders in the medical device community through a proven track record of innovative materials science, engineering, and manufacturing. For more information, visit confluentmedical.com.

Media:
Brittany Mai
brittany.mai@confluentmedical.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  239.30
+0.00 (0.00%)
AAPL  259.48
+0.00 (0.00%)
AMD  236.73
+0.00 (0.00%)
BAC  53.20
+0.00 (0.00%)
GOOG  338.53
+0.00 (0.00%)
META  716.50
+0.00 (0.00%)
MSFT  430.29
+0.00 (0.00%)
NVDA  191.13
+0.00 (0.00%)
ORCL  164.58
+0.00 (0.00%)
TSLA  430.41
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.